Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

FDA grants Breakthrough Device Designation for Smart orthopedic implants

Cork, Ireland, Gothenburg, Sweden & Houston, Texas (May 28, 2021) -- Intelligent Implants Ltd (II), a development-stage, medical device company with offices in Cork, Ireland, Gothenburg, Sweden and Houston, Texas has announced today that its SmartFuse® system has received Breakthrough Device Designation by the US Food and Drug Administration (FDA). Intelligent Implants SmartFuse technology is a wirelessly enabled orthopedics platform that has been designed to remotely stimulate, control, and monitor bone growth. The goal of the SmartFuse system is to accelerate bone growth and provide

Maersk selects Wärtsilä hybrid solution to support decarbonisation efforts

Wärtsilä Corporation, Press release, 28 May 2021 at 3.15 pm EESTThe technology group Wärtsilä will supply its Wärtsilä HY Module , a containerised hybrid battery power and energy storage system to Maersk Supply Service, the Denmark based provider of offshore marine services and integrated solutions for the global energy sector. The Wärtsilä system will support Maersk’s goal of reducing the carbon intensity of its fleet by 50 percent before the end of this decade. The order with Wärtsilä was placed in May 2021. The hybrid power conversion will be carried out on

Interim Report 28[th] December 2020 to 28[th] March 2021

FRIDAY, 28[th] MAY, 14:00 CETJANUARY to MARCH 2021 · Net sales amounted to £26.3 million · EBITDA before special items amounted to £5,983k up 10.4% on the same quarter last year · Operating profit amounted to £4,561k · Profit before tax amounted to £5,405k · Cash and cash equivalents at the end of the period were £36,573k  Q2 revenues were 7.2% below the same quarter last year due to the inability to deliver in Scotland during the lockdown and the timing of the Christmas holidays.  EBITDA increased by £562k to £5,983k over the same quarter as the previous year despite

New store to take title of northernmost Tokmanni in Finland – Store network to expand to Kittilä, near Levi and Ylläs

Tokmanni     Press release     28 May 2021 at 2:45 p.m. Tokmanni, Finland’s largest general discount retailer, has signed an agreement on the opening of a new store in Kittilä, at the address Aakenuksentie 30, 99100 Kittilä. The aim is to open the new store in a new, yet unconstructed commercial building before the end of the current year. Once the new store opens, the Tokmanni in Sodankylä will relinquish its title of northernmost Tokmanni store to Kittilä. The new Tokmanni store will be serving its customers in a good location in the immediate vicinity of the junction between

BioStock: Spotlight on MS

World MS Day will be celebrated on Sunday May 30th. It is a day to raise awareness of the condition, and to support and connect people living with the disease worldwide. Although over 2.5 million people are suffering from multiple sclerosis there is currently no treatment that is efficient across all patient groups. To fill this void the Swedish biotech company Cyxone is intensifying its efforts on their drug candidate, T20K, intended for a long-term MS treatment to stop disease progression, avoiding devastating side effects and more convenient to take compared to existing treatments.Read

Notice of Biohit Oyj’s annual general meeting

Biohit Oyj Stock Exchange Release May 28, 2021 at 02:00 pm local time (EEST)   Biohit Oyj shareholders are invited to attend the company’s Annual General Meeting to be held on Wednesday, June 23, 2021 starting at 11:00 am at the Company’s headquarter. The address is Laippatie 1, 00880 Helsinki. Participation and exercise of shareholder rights in the Meeting by shareholders or their proxy representatives is possible only by voting in advance and by submitting counterproposals and asking questions in advance in accordance with the instructions given in this notice and otherwise by the

Publication of Biohit Oyj Renumeration Report 2020

Biohit Oyj Renumeration Report May 28, 2021 at 02:00 pm local time (EET)   Biohit Oyj’s Remuneration Report for the Governing Bodies is published today in PDF format. The Remuneration Report for the Governing Bodies is attached to this stock exchange release and also available at https://www.biohithealthcare.com/en/investors/. Additional information: Chairman of the Board Osmo Suovaniemi, Biohit Oyjtel. +358 9 773 861investor.relations@biohit.fiwww.biohithealthcare.com 

LKAB develops a new mining method

When mining depths in underground mines increase, so do the challenges. Therefore, an entirely new method has been developed – raise caving. This is a major groundbreaking step towards a safer, more efficient mine."Raise caving has been developed for efficient mining at great depth," says Matthias Wimmer, mining engineering manager at LKAB in Kiruna.Rock stresses increase as mining moves to ever greater depth. A more complex geometry, in combination with rock-mechanical challenges, places demands on new, sustainable and innovative solutions for the mine of the future. And, underground,

Decisions by the Annual General Meeting of Apetit Plc

Apetit Plc, Stock exchange release, 28 May 2021 at 2.00 p.m.Decisions by the Annual General Meeting of Apetit Plc The Annual General Meeting on 28 May 2021 approved the parent company's and consolidated financial statements for the financial year 1 January - 31 December 2020 and discharged the members of the Supervisory Board and the Board of Directors and the CEO from liability. The Board of Directors' proposals were approved without changes. DIVIDEND The Annual General Meeting decided that a dividend of EUR 0.50 per share will be paid for the financial year 2020. The dividend

Susanne Ohlsén Appointed as Managing Director Teknos Sweden

Teknos is pleased to announce the appointment of Susanne Ohlsén as Managing Director for Teknos Sweden starting from 1st of August 2021.Teknos is pleased to announce the appointment of Susanne Ohlsén as Managing Director for Teknos Sweden starting from 1st of August 2021.   Susanne joined Teknos in June 2018 as HR Manager where she streamlined the HR processes and increased the efficiency of our HR routines in Sweden. In her role as HR manager, Susanne is also a member of the Teknos Group HR Council and has also taken on leading responsibilities for strategic projects within the company.

Flowscape receives software order in the UK and Ireland

A British company in the financial services sector has selected Flowscape's solution to book desks and parking spaces for all three of its offices in Great Britain and Ireland. The solution is considered a key element of their digital workplace strategy post-pandemic. The order value in the first year is GBP 40,000 and thereafter GBP 32,000 annually."The UK is now starting to reopen, and we are seeing an increasing number of incoming requests for our products. This customer enquiry was received from our website and following a pilot, they have now chosen to implement Flowscape's solution in

CEO Patrik Dahlen purchases Immunovia shares

LUND, SWEDEN - Immunovia AB (publ) (“Immunovia”) announces today that Patrik Dahlen, CEO of Immunovia, has purchased 6,860 shares for approximately SEK 675,000 over the stock exchange. His total holding now amounts to 51,860 shares in Immunovia. For more information, please contact:Patrik Dahlen, CEO ImmunoviaEmail: patrik.dahlen@immunovia.comTel: +46 73 376 76 64 About ImmunoviaImmunovia AB is a diagnostic company that is developing and commercializing highly accurate blood tests for the early detection of cancer and autoimmune diseases based on Immunovia’s proprietary test

Invitation to NoHo Partners' Strategy briefing on Friday, 11 June 2021 at 10:00 a.m.

NoHo Partners Plc INVESTOR NEWS 28 May 2021 at 13:30Invitation to NoHo Partners' Strategy briefing on Friday, 11 June 2021 at 10:00 a.m.NoHo Partners Plc will publish its strategy and financial targets for the strategy period 2022–2024 on Friday, 11 June 2021. The company has brought forward the publication of the strategy and long-term financial targets as previously announced in the Q1/2021 interim report.A strategy briefing for the analysts, media and investors will be organised on the same day, at 10:00 a.m., where the company will explain more about it its strategy and

Calliditas Therapeutics to Present at Jefferies Virtual Healthcare Conference

Calliditas Therapeutics AB (publ) (“Calliditas”) today announced that management will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021 at 2:30 pm CET/8:30 am ET. Calliditas will also host 1x1 meetings during the conference. Details for the presentation are as follows:Jefferies Virtual Healthcare Conference Date: Tuesday, June 1, 2021 Time: 2:30 pm CET / 8:30 am ET Registration Link: https://wsw.com/webcast/jeff174/register.aspx?conf=jeff174&page=calt&mmid=3325730&refer=meetmax&firstname=&lastname= The webcast will be archived for a period of 30

EWPG Holding AB (publ) Annual Report 2020 published

28/05/2021- Stockholm, Sweden - EWPG Holding AB (publ) Annual Report 2020 is attached to this press release and available at https://www.ecowavepower.com/investor-relations/financial-reports/. For the full report, please click here . About EWPG Holding AB (SE0012569663) EWPG Holding AB (publ) (“Eco Wave Power”) is a leading onshore wave energy technology company that developed a patented, smart and cost-efficient technology for turning ocean and sea waves into green electricity. Eco Wave Power’

Orkla ASA – Issuance of Commercial Paper

Orkla ASA has issued a commercial paper of NOK 500,000,000.Start date:                   1 June 2021 Maturity:                     1 September 2021 Coupon:                      0.34 % Organised by:             Handelsbanken Capital Markets         Orkla ASA Oslo, 28 May 2021   Ref.: Senior Vice President Group Treasury Geir Solli Tel.: +47 995 42 789

Artificial Solutions Extends Existing 52 MSEK Bond

Artificial Solutions International AB (“Artificial Solutions” or the “Company”) today announces the extension of the existing 52 MSEK bond.Artificial Solutions today announces that the Company has agreed a 4-month extension of the 52 MSEK bond. Previously the bond was due for repayment on June 5, 2021. Repayment of the bond will now be due for repayment on the October 5, 2021. All other terms remain the same.

Cline Scientific AB receives conditional approval for list change to Nasdaq First North Growth Market in Stockholm

Cline Scientific AB (publ) ("Cline" or "the Company") has applied for and received conditional approval for admission to trading on the Nasdaq First North Growth Market ("Nasdaq First North"). As a result, the Company's delisting application has also been approved by Spotlight. The company's last day for trading on the Spotlight Stock Market is June 11, 2021. The first day for trading on Nasdaq First North is June 14, 2021. Shareholders in Cline Scientific will not have to take any action in connection with the list change. Clines shares are currently traded on the Stocklight Stock

Product recall: Fazer Confectionery is recalling a batch of Fazer Pure Dark 70 % Cocoa chocolate tablets

As a safety precaution, Fazer Confectionery is recalling a batch of Fazer Pure Dark 70 % Cocoa chocolate tablets with ‘best before’ date 26.4.2022. Due to an error which occurred during product changeover, a small batch of Fazer Pure Dark 70 % Cocoa chocolate tablets may contain small amounts of milk chocolate. The product is safe to use except for those who are allergic to milk or sensitive to lactose. The recall concerns the following batch: Fazer Pure Dark 70% Cocoa dark chocolate 95gBest before date 26.4.2022 Milk is not among the ingredients of Fazer Pure Dark 70% Cocoa.

Bulletin from Extraordinary General Meeting of Knowit Aktiebolag (publ)

Knowit Aktiebolag (publ) has this day held a Extraordinary General Meeting.The General Meeting mainly resolved on the following. For more detailed information on the content of the resolutions, please refer to the full notice to attend the General Meeting and the full proposals that are available on the company’s webpage, www.knowit.eu. The General Meeting resolved, in accordance with the Board of Director’s proposal, to authorize the Board of Directors, during the period up until the next Annual General Meeting, to resolve on a share issue in kind of a maximum of 5,760,883 shares for

"There must be academic proof that digital dental tools are reliable"

Dr János Vág DMD, PhD, is an Associate Professor and the Head of Department for Conservative Dentistry at the Semmelweis University in Hungary. In the past few years, his research has focused on digital dentistry and evaluating the accuracy of CAD/CAM systems. In addition to having published 49 articles in peer-reviewed journals, Dr Vág has vast experience from clinical work at a dental clinic as well. Therefore, he can tell a thing or two about the importance of dental research for clinical work as well as the benefits of going digital. Dr Janos Vág became a dentist of necessity,

Subaru Levorg with Veoneer technologies wins prestigious Best 5-Star Award in Japan NCAP

Stockholm, Sweden, May 28, 2021: The automotive technology company Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB), is proud active safety supplier to Subaru Levorg, awarded top results in the Japan NCAP (JNCAP).In Japan NCAP’s latest annual safety testing, Subaru Levorg outperformed the 10 vehicles rated with 5 stars and an overall rating above 98%. At the heart of Subaru Levorg’s active safety system is the new generation EyeSight hardware, a variant of Veoneer’s 4[th] generation stereo vision system, re-engineered to meet Subaru’s original specification. The new generation EyeSight has two

There are no items matching the current filter
There are no more items matching the current filter
Back to top